메뉴 건너뛰기




Volumn 47, Issue 3, 2015, Pages 181-190

Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome

Author keywords

Dissociation; Insulin resistance; Natural history; Pathogenesis

Indexed keywords

AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

EID: 84923918979     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.09.020     Document Type: Review
Times cited : (550)

References (234)
  • 1
    • 0037129380 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease
    • Angulo P. Non-alcoholic fatty liver disease. New England Journal of Medicine 2002, 346:1221-1231.
    • (2002) New England Journal of Medicine , vol.346 , pp. 1221-1231
    • Angulo, P.1
  • 3
    • 84884419004 scopus 로고    scopus 로고
    • From NAFLD in clinical practice to answers from guidelines
    • Nascimbeni F., Pais R., Bellentani S., et al. From NAFLD in clinical practice to answers from guidelines. Journal of Hepatology 2013, 59:859-871.
    • (2013) Journal of Hepatology , vol.59 , pp. 859-871
    • Nascimbeni, F.1    Pais, R.2    Bellentani, S.3
  • 4
    • 1642355723 scopus 로고    scopus 로고
    • The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease
    • Caldwell S.H., Crespo D.M. The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease. Journal of Hepatology 2004, 40:578-584.
    • (2004) Journal of Hepatology , vol.40 , pp. 578-584
    • Caldwell, S.H.1    Crespo, D.M.2
  • 5
    • 84879110184 scopus 로고    scopus 로고
    • Hepatic fat loss in advanced non-alcoholic steatohepatitis: are alterations in serum adiponectin the cause?
    • van der Poorten D., Samer C.F., Ramezani-Moghadam M., et al. Hepatic fat loss in advanced non-alcoholic steatohepatitis: are alterations in serum adiponectin the cause?. Hepatology 2013, 57:2180-2188.
    • (2013) Hepatology , vol.57 , pp. 2180-2188
    • van der Poorten, D.1    Samer, C.F.2    Ramezani-Moghadam, M.3
  • 6
    • 84881232944 scopus 로고    scopus 로고
    • Cardiovascular and systemic risk in non-alcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD
    • Lonardo A., Sookoian S., Chonchol M., et al. Cardiovascular and systemic risk in non-alcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD. Current Pharmaceutical Design 2013, 19:5177-5192.
    • (2013) Current Pharmaceutical Design , vol.19 , pp. 5177-5192
    • Lonardo, A.1    Sookoian, S.2    Chonchol, M.3
  • 7
    • 0034862590 scopus 로고    scopus 로고
    • Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology
    • Skelly M.M., James P.D., Ryder S.D. Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology. Journal of Hepatology 2001, 35:195-199.
    • (2001) Journal of Hepatology , vol.35 , pp. 195-199
    • Skelly, M.M.1    James, P.D.2    Ryder, S.D.3
  • 9
    • 84901616858 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the US
    • Wong R.J., Cheung R., Ahmed A. Non-alcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the US. Hepatology 2014, 59:2188-2195.
    • (2014) Hepatology , vol.59 , pp. 2188-2195
    • Wong, R.J.1    Cheung, R.2    Ahmed, A.3
  • 10
    • 1442275319 scopus 로고    scopus 로고
    • Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study
    • Palaniappan L., Carnethon M.R., Wang Y., et al. Predictors of the incident metabolic syndrome in adults: the Insulin Resistance Atherosclerosis Study. Diabetes Care 2004, 27:788-793.
    • (2004) Diabetes Care , vol.27 , pp. 788-793
    • Palaniappan, L.1    Carnethon, M.R.2    Wang, Y.3
  • 11
    • 73949115305 scopus 로고    scopus 로고
    • The metabolic syndrome
    • Eckel R.H. The metabolic syndrome. Lancet 2010, 375:181-183.
    • (2010) Lancet , vol.375 , pp. 181-183
    • Eckel, R.H.1
  • 13
    • 44449129581 scopus 로고    scopus 로고
    • Should non-alcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects
    • Musso G., Gambino R., Bo S., et al. Should non-alcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects. Diabetes Care 2008, 31:562-568.
    • (2008) Diabetes Care , vol.31 , pp. 562-568
    • Musso, G.1    Gambino, R.2    Bo, S.3
  • 15
    • 77957198071 scopus 로고    scopus 로고
    • The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis
    • Mottillo S., Filion K.B., Genest J., et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. Journal of the American College of Cardiology 2010, 56:1113-1132.
    • (2010) Journal of the American College of Cardiology , vol.56 , pp. 1113-1132
    • Mottillo, S.1    Filion, K.B.2    Genest, J.3
  • 16
    • 84860143561 scopus 로고    scopus 로고
    • Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study
    • Rachas A., Raffaitin C., Barberger-Gateau P., et al. Clinical usefulness of the metabolic syndrome for the risk of coronary heart disease does not exceed the sum of its individual components in older men and women. The Three-City (3C) Study. Heart 2012, 98:650-655.
    • (2012) Heart , vol.98 , pp. 650-655
    • Rachas, A.1    Raffaitin, C.2    Barberger-Gateau, P.3
  • 17
    • 84859738756 scopus 로고    scopus 로고
    • Predictors of the development of metabolic syndrome in male workers: a 3-year follow-up study
    • Kawada T. Predictors of the development of metabolic syndrome in male workers: a 3-year follow-up study. Journal of Occupational and Environmental Medicine 2012, 54:292-295.
    • (2012) Journal of Occupational and Environmental Medicine , vol.54 , pp. 292-295
    • Kawada, T.1
  • 18
    • 33748776056 scopus 로고    scopus 로고
    • Metabolic syndrome and risk of cardiovascular disease: a meta-analysis
    • Galassi A., Reynolds K., He J. Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. American Journal of Medicine 2006, 119:812-819.
    • (2006) American Journal of Medicine , vol.119 , pp. 812-819
    • Galassi, A.1    Reynolds, K.2    He, J.3
  • 19
    • 79960747094 scopus 로고    scopus 로고
    • Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database
    • Welzel T.M., Graubard B.I., Zeuzem S., et al. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology 2011, 54:463-471.
    • (2011) Hepatology , vol.54 , pp. 463-471
    • Welzel, T.M.1    Graubard, B.I.2    Zeuzem, S.3
  • 20
    • 0032828612 scopus 로고    scopus 로고
    • Fatty liver and non-alcoholic steatohepatitis. Where do we stand and where are we going?
    • Lonardo A. Fatty liver and non-alcoholic steatohepatitis. Where do we stand and where are we going?. Digestive Diseases 1999, 17:80-89.
    • (1999) Digestive Diseases , vol.17 , pp. 80-89
    • Lonardo, A.1
  • 21
    • 0033231294 scopus 로고    scopus 로고
    • Association of non-alcoholic fatty liver disease with insulin resistance
    • Marchesini G., Brizi M., Morselli-Labate A.M., et al. Association of non-alcoholic fatty liver disease with insulin resistance. American Journal of Medicine 1999, 107:450-455.
    • (1999) American Journal of Medicine , vol.107 , pp. 450-455
    • Marchesini, G.1    Brizi, M.2    Morselli-Labate, A.M.3
  • 22
    • 0033373699 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver: another feature of the metabolic syndrome?
    • Cortez-Pinto H., Camilo M.E., Baptista A., et al. Non-alcoholic fatty liver: another feature of the metabolic syndrome?. Clinical Nutrition 1999, 18:353-358.
    • (1999) Clinical Nutrition , vol.18 , pp. 353-358
    • Cortez-Pinto, H.1    Camilo, M.E.2    Baptista, A.3
  • 26
    • 84902672359 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
    • Yki-Järvinen H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. The Lancet Diabetes & Endocrinology 2014, 2:901-910.
    • (2014) The Lancet Diabetes & Endocrinology , vol.2 , pp. 901-910
    • Yki-Järvinen, H.1
  • 27
    • 0033863209 scopus 로고    scopus 로고
    • Are there any sex differences in fatty liver? A study of glucose metabolism and body fat distribution
    • Lonardo A., Trande P. Are there any sex differences in fatty liver? A study of glucose metabolism and body fat distribution. Journal of Gastroenterology and Hepatology 2000, 15:775-782.
    • (2000) Journal of Gastroenterology and Hepatology , vol.15 , pp. 775-782
    • Lonardo, A.1    Trande, P.2
  • 28
    • 0035431018 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease: a feature of the metabolic syndrome
    • Marchesini G., Brizi M., Bianchi G., et al. Non-alcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001, 50:1844-1850.
    • (2001) Diabetes , vol.50 , pp. 1844-1850
    • Marchesini, G.1    Brizi, M.2    Bianchi, G.3
  • 29
    • 24044467100 scopus 로고    scopus 로고
    • Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults
    • Jimba S., Nakagami T., Takahashi M., et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabetic Medicine 2005, 22:1141-1145.
    • (2005) Diabetic Medicine , vol.22 , pp. 1141-1145
    • Jimba, S.1    Nakagami, T.2    Takahashi, M.3
  • 30
    • 33748911973 scopus 로고    scopus 로고
    • Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease
    • Wong V.W., Hui A.Y., Tsang S.W., et al. Prevalence of undiagnosed diabetes and postchallenge hyperglycaemia in Chinese patients with non-alcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 2006, 24:1215-1222.
    • (2006) Alimentary Pharmacology and Therapeutics , vol.24 , pp. 1215-1222
    • Wong, V.W.1    Hui, A.Y.2    Tsang, S.W.3
  • 31
    • 66149119340 scopus 로고    scopus 로고
    • Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population
    • Gastaldelli A., Kozakova M., Højlund K., et al. Fatty liver is associated with insulin resistance, risk of coronary heart disease, and early atherosclerosis in a large European population. Hepatology 2009, 49:1537-1544.
    • (2009) Hepatology , vol.49 , pp. 1537-1544
    • Gastaldelli, A.1    Kozakova, M.2    Højlund, K.3
  • 32
    • 77952680758 scopus 로고    scopus 로고
    • Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study
    • Speliotes E.K., Massaro J.M., Hoffmann U., et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology 2010, 51:1979-1987.
    • (2010) Hepatology , vol.51 , pp. 1979-1987
    • Speliotes, E.K.1    Massaro, J.M.2    Hoffmann, U.3
  • 33
    • 79955731194 scopus 로고    scopus 로고
    • Associations between combinations of body mass index plus non-alcoholic fatty liver disease and diabetes mellitus among Korean adults
    • Kim S.H., Lee J.W., Hwang H.J. Associations between combinations of body mass index plus non-alcoholic fatty liver disease and diabetes mellitus among Korean adults. Asia Pacific Journal of Clinical Nutrition 2011, 20:14-20.
    • (2011) Asia Pacific Journal of Clinical Nutrition , vol.20 , pp. 14-20
    • Kim, S.H.1    Lee, J.W.2    Hwang, H.J.3
  • 34
    • 84856621545 scopus 로고    scopus 로고
    • Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children
    • Bedogni G., Gastaldelli A., Manco M., et al. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children. Nutrition, Metabolism and Cardiovascular Diseases 2012, 22:120-126.
    • (2012) Nutrition, Metabolism and Cardiovascular Diseases , vol.22 , pp. 120-126
    • Bedogni, G.1    Gastaldelli, A.2    Manco, M.3
  • 35
    • 84859393575 scopus 로고    scopus 로고
    • Prevalence of prediabetes and diabetes and metabolic profile of patients with non-alcoholic fatty liver disease (NAFLD)
    • Ortiz-Lopez C., Lomonaco R., Orsak B., et al. Prevalence of prediabetes and diabetes and metabolic profile of patients with non-alcoholic fatty liver disease (NAFLD). Diabetes Care 2012, 35:873-878.
    • (2012) Diabetes Care , vol.35 , pp. 873-878
    • Ortiz-Lopez, C.1    Lomonaco, R.2    Orsak, B.3
  • 36
    • 84871772924 scopus 로고    scopus 로고
    • Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study
    • Porter S.A., Pedley A., Massaro J.M., et al. Aminotransferase levels are associated with cardiometabolic risk above and beyond visceral fat and insulin resistance: the Framingham Heart Study. Arteriosclerosis, Thrombosis, and Vascular Biology 2013, 33:139-146.
    • (2013) Arteriosclerosis, Thrombosis, and Vascular Biology , vol.33 , pp. 139-146
    • Porter, S.A.1    Pedley, A.2    Massaro, J.M.3
  • 37
    • 84880245463 scopus 로고    scopus 로고
    • Prevalence of non-alcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994
    • Lazo M., Hernaez R., Eberhardt M.S., et al. Prevalence of non-alcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988-1994. American Journal of Epidemiology 2013, 178:38-45.
    • (2013) American Journal of Epidemiology , vol.178 , pp. 38-45
    • Lazo, M.1    Hernaez, R.2    Eberhardt, M.S.3
  • 38
    • 84879779516 scopus 로고    scopus 로고
    • Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese
    • Li X., Xia M., Ma H., et al. Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in Chinese. PLOS ONE 2013, 8:e65210.
    • (2013) PLOS ONE , vol.8 , pp. e65210
    • Li, X.1    Xia, M.2    Ma, H.3
  • 39
    • 84877016638 scopus 로고    scopus 로고
    • The association between non-alcoholic fatty pancreas disease and diabetes
    • Ou H.Y., Wang C.Y., Yang Y.C., et al. The association between non-alcoholic fatty pancreas disease and diabetes. PLOS ONE 2013, 8:e62561.
    • (2013) PLOS ONE , vol.8 , pp. e62561
    • Ou, H.Y.1    Wang, C.Y.2    Yang, Y.C.3
  • 41
    • 80555136061 scopus 로고    scopus 로고
    • Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
    • Musso G., Gambino R., Cassader M., et al. Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity. Annals of Medicine 2011, 43:617-649.
    • (2011) Annals of Medicine , vol.43 , pp. 617-649
    • Musso, G.1    Gambino, R.2    Cassader, M.3
  • 42
    • 0001271970 scopus 로고
    • Serum gamma-glutamyl transpeptidase levels and hypertension in non-drinkers: a possible role of fatty liver in the pathogenesis of obesity related hypertension
    • Ikai E., Noborizaka Y., Tsuritani I., et al. Serum gamma-glutamyl transpeptidase levels and hypertension in non-drinkers: a possible role of fatty liver in the pathogenesis of obesity related hypertension. Obesity Research 1993, 1:469-474.
    • (1993) Obesity Research , vol.1 , pp. 469-474
    • Ikai, E.1    Noborizaka, Y.2    Tsuritani, I.3
  • 43
    • 3042521502 scopus 로고    scopus 로고
    • Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance
    • Donati G., Stagni B., Piscaglia F., et al. Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistance. Gut 2004, 53:1020-1023.
    • (2004) Gut , vol.53 , pp. 1020-1023
    • Donati, G.1    Stagni, B.2    Piscaglia, F.3
  • 45
    • 0033055916 scopus 로고    scopus 로고
    • Fatty liver - an additional and treatable feature of the insulin resistance syndrome
    • Knobler H., Schattner A., Zhornicki T., et al. Fatty liver - an additional and treatable feature of the insulin resistance syndrome. QJM 1999 Feb, 92:73-79.
    • (1999) QJM , vol.92 , pp. 73-79
    • Knobler, H.1    Schattner, A.2    Zhornicki, T.3
  • 46
    • 23044476866 scopus 로고    scopus 로고
    • Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome
    • Marchesini G., Avagnina S., Barantani E.G., et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. Journal of Endocrinological Investigation 2005, 28:333-339.
    • (2005) Journal of Endocrinological Investigation , vol.28 , pp. 333-339
    • Marchesini, G.1    Avagnina, S.2    Barantani, E.G.3
  • 47
  • 49
    • 73249126258 scopus 로고    scopus 로고
    • Serum gamma-glutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals
    • Kawamoto R., Kohara K., Tabara Y., et al. Serum gamma-glutamyl transferase levels are associated with metabolic syndrome in community-dwelling individuals. Journal of Atherosclerosis and Thrombosis 2009, 16:355-362.
    • (2009) Journal of Atherosclerosis and Thrombosis , vol.16 , pp. 355-362
    • Kawamoto, R.1    Kohara, K.2    Tabara, Y.3
  • 50
    • 78449286054 scopus 로고    scopus 로고
    • A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients
    • Anty R., Iannelli A., Patouraux S., et al. A new composite model including metabolic syndrome, alanine aminotransferase and cytokeratin-18 for the diagnosis of non-alcoholic steatohepatitis in morbidly obese patients. Alimentary Pharmacology and Therapeutics 2010, 32:1315-1322.
    • (2010) Alimentary Pharmacology and Therapeutics , vol.32 , pp. 1315-1322
    • Anty, R.1    Iannelli, A.2    Patouraux, S.3
  • 52
    • 80053649814 scopus 로고    scopus 로고
    • Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD
    • Boursier J., Chaigneau J., Roullier V., et al. Steatosis degree, measured by morphometry, is linked to other liver lesions and metabolic syndrome components in patients with NAFLD. European Journal of Gastroenterology and Hepatology 2011, 23:974-981.
    • (2011) European Journal of Gastroenterology and Hepatology , vol.23 , pp. 974-981
    • Boursier, J.1    Chaigneau, J.2    Roullier, V.3
  • 53
    • 84869166012 scopus 로고    scopus 로고
    • Prevalence and factors associated with non-alcoholic fatty liver disease in Shanghai work-units
    • Hu X., Huang Y., Bao Z., et al. Prevalence and factors associated with non-alcoholic fatty liver disease in Shanghai work-units. BMC Gastroenterology 2012, 12:123.
    • (2012) BMC Gastroenterology , vol.12 , pp. 123
    • Hu, X.1    Huang, Y.2    Bao, Z.3
  • 54
    • 84860330650 scopus 로고    scopus 로고
    • Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome
    • Pickhardt P.J., Jee Y., O'Connor S.D., et al. Visceral adiposity and hepatic steatosis at abdominal CT: association with the metabolic syndrome. American Journal of Roentgenology 2012, 198:1100-1107.
    • (2012) American Journal of Roentgenology , vol.198 , pp. 1100-1107
    • Pickhardt, P.J.1    Jee, Y.2    O'Connor, S.D.3
  • 56
    • 84870855668 scopus 로고    scopus 로고
    • Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults
    • Kwon Y.M., Oh S.W., Hwang S.S., et al. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. American Journal of Gastroenterology 2012, 107:1852-1858.
    • (2012) American Journal of Gastroenterology , vol.107 , pp. 1852-1858
    • Kwon, Y.M.1    Oh, S.W.2    Hwang, S.S.3
  • 57
    • 84859611672 scopus 로고    scopus 로고
    • Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults
    • Sinn D.H., Gwak G.Y., Park H.N., et al. Ultrasonographically detected non-alcoholic fatty liver disease is an independent predictor for identifying patients with insulin resistance in non-obese, non-diabetic middle-aged Asian adults. American Journal of Gastroenterology 2012, 107:561-567.
    • (2012) American Journal of Gastroenterology , vol.107 , pp. 561-567
    • Sinn, D.H.1    Gwak, G.Y.2    Park, H.N.3
  • 58
    • 84869498671 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease in lean individuals in the United States
    • Younossi Z.M., Stepanova M., Negro F., et al. Non-alcoholic fatty liver disease in lean individuals in the United States. Medicine 2012, 91:319-327.
    • (2012) Medicine , vol.91 , pp. 319-327
    • Younossi, Z.M.1    Stepanova, M.2    Negro, F.3
  • 59
    • 84870417160 scopus 로고    scopus 로고
    • Role of gamma-glutamyl transferase (GGT) in diagnosis of impaired glucose tolerance and metabolic syndrome: a prospective cohort research from the Kerman Coronary Artery Disease Risk Study (KERCADRS)
    • Yousefzadeh G., Shokoohi M., Yeganeh M., et al. Role of gamma-glutamyl transferase (GGT) in diagnosis of impaired glucose tolerance and metabolic syndrome: a prospective cohort research from the Kerman Coronary Artery Disease Risk Study (KERCADRS). Diabetology & Metabolic Syndrome 2012, 6:190-194.
    • (2012) Diabetology & Metabolic Syndrome , vol.6 , pp. 190-194
    • Yousefzadeh, G.1    Shokoohi, M.2    Yeganeh, M.3
  • 60
    • 84880925165 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society
    • Soresi M., Noto D., Cefalù A.B., et al. Non-alcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society. Acta Diabetologica 2013, 50:241-249.
    • (2013) Acta Diabetologica , vol.50 , pp. 241-249
    • Soresi, M.1    Noto, D.2    Cefalù, A.B.3
  • 61
    • 84875625146 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups
    • Smits M.M., Ioannou G.N., Boyko E.J., et al. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: results of a US national survey in three ethnic groups. Journal of Gastroenterology and Hepatology 2013, 28:664-670.
    • (2013) Journal of Gastroenterology and Hepatology , vol.28 , pp. 664-670
    • Smits, M.M.1    Ioannou, G.N.2    Boyko, E.J.3
  • 62
    • 84886687873 scopus 로고    scopus 로고
    • Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease
    • Eraslan S., Kizilgul M., Uzunlulu M., et al. Frequency of metabolic syndrome and 25-hydroxyvitamin D3 levels in patients with non-alcoholic fatty liver disease. Minerva Medica 2013, 104:447-453.
    • (2013) Minerva Medica , vol.104 , pp. 447-453
    • Eraslan, S.1    Kizilgul, M.2    Uzunlulu, M.3
  • 63
    • 84878223812 scopus 로고    scopus 로고
    • Fatty liver increases the association of metabolic syndrome with diabetes and atherosclerosis
    • Juárez-Rojas J.G., Medina-Urrutia A.X., Jorge-Galarza E., et al. Fatty liver increases the association of metabolic syndrome with diabetes and atherosclerosis. Diabetes Care 2013, 36:1726-1728.
    • (2013) Diabetes Care , vol.36 , pp. 1726-1728
    • Juárez-Rojas, J.G.1    Medina-Urrutia, A.X.2    Jorge-Galarza, E.3
  • 64
    • 84887376215 scopus 로고    scopus 로고
    • Association between γ-glutamyl transferase and metabolic syndrome: a cross-sectional study of an adult population in Beijing
    • Tao L., Li X., Zhu H., et al. Association between γ-glutamyl transferase and metabolic syndrome: a cross-sectional study of an adult population in Beijing. International Journal of Environmental Research and Public Health 2013, 10:5523-5540.
    • (2013) International Journal of Environmental Research and Public Health , vol.10 , pp. 5523-5540
    • Tao, L.1    Li, X.2    Zhu, H.3
  • 65
    • 65349101599 scopus 로고    scopus 로고
    • Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis
    • Fraser A., Harris R., Sattar N., et al. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes: the British Women's Heart and Health Study and meta-analysis. Diabetes Care 2009, 32:741-750.
    • (2009) Diabetes Care , vol.32 , pp. 741-750
    • Fraser, A.1    Harris, R.2    Sattar, N.3
  • 66
    • 18344386388 scopus 로고    scopus 로고
    • Policentrica Steatosi Epatica Non Alcolica. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study
    • Lonardo A., Loria P., Leonardi F., et al. Policentrica Steatosi Epatica Non Alcolica. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Digestive and Liver Disease 2002, 34:204-211.
    • (2002) Digestive and Liver Disease , vol.34 , pp. 204-211
    • Lonardo, A.1    Loria, P.2    Leonardi, F.3
  • 67
    • 80052501527 scopus 로고    scopus 로고
    • Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease
    • Petta S., Cammà C., Cabibi D., et al. Hyperuricemia is associated with histological liver damage in patients with non-alcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 2011, 34:757-766.
    • (2011) Alimentary Pharmacology and Therapeutics , vol.34 , pp. 757-766
    • Petta, S.1    Cammà, C.2    Cabibi, D.3
  • 68
    • 84870289648 scopus 로고    scopus 로고
    • Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis
    • Keenan T., Blaha M.J., Nasir K., et al. Relation of uric acid to serum levels of high-sensitivity C-reactive protein, triglycerides, and high-density lipoprotein cholesterol and to hepatic steatosis. American Journal of Cardiology 2012, 110:1787-1792.
    • (2012) American Journal of Cardiology , vol.110 , pp. 1787-1792
    • Keenan, T.1    Blaha, M.J.2    Nasir, K.3
  • 69
    • 33947369055 scopus 로고    scopus 로고
    • Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39
    • Ryu S., Song J., Choi B.Y., et al. Incidence and risk factors for metabolic syndrome in Korean male workers, ages 30 to 39. Annals of Epidemiology 2007, 17:245-252.
    • (2007) Annals of Epidemiology , vol.17 , pp. 245-252
    • Ryu, S.1    Song, J.2    Choi, B.Y.3
  • 72
    • 84861938931 scopus 로고    scopus 로고
    • A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population
    • Zhang Q., Zhang C., Song X., et al. A longitudinal cohort based association study between uric acid level and metabolic syndrome in Chinese Han urban male population. BMC Public Health 2012, 12:419.
    • (2012) BMC Public Health , vol.12 , pp. 419
    • Zhang, Q.1    Zhang, C.2    Song, X.3
  • 73
    • 84866732607 scopus 로고    scopus 로고
    • Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents
    • 753-6.e2
    • Wang J.Y., Chen Y.L., Hsu C.H., et al. Predictive value of serum uric acid levels for the diagnosis of metabolic syndrome in adolescents. Journal of Pediatrics 2012, 161. 753-6.e2.
    • (2012) Journal of Pediatrics , vol.161
    • Wang, J.Y.1    Chen, Y.L.2    Hsu, C.H.3
  • 74
    • 84857921905 scopus 로고    scopus 로고
    • Relationship between serum uric acid and metabolic syndrome: an analysis by structural equation modeling
    • Lu W., Song K., Wang Y., et al. Relationship between serum uric acid and metabolic syndrome: an analysis by structural equation modeling. Journal of Clinical Lipidology 2012, 6:159-167.
    • (2012) Journal of Clinical Lipidology , vol.6 , pp. 159-167
    • Lu, W.1    Song, K.2    Wang, Y.3
  • 75
    • 84855932028 scopus 로고    scopus 로고
    • Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study
    • Yang T., Chu C.H., Bai C.H., et al. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study. Atherosclerosis 2012, 220:525-531.
    • (2012) Atherosclerosis , vol.220 , pp. 525-531
    • Yang, T.1    Chu, C.H.2    Bai, C.H.3
  • 76
    • 84862731971 scopus 로고    scopus 로고
    • Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men
    • Zhang Z., Bian L., Choi Y. Serum uric acid: a marker of metabolic syndrome and subclinical atherosclerosis in Korean men. Angiology 2012, 63:420-428.
    • (2012) Angiology , vol.63 , pp. 420-428
    • Zhang, Z.1    Bian, L.2    Choi, Y.3
  • 77
    • 84862648876 scopus 로고    scopus 로고
    • Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome
    • Gonçalves J.P., Oliveira A., Severo M., et al. Cross-sectional and longitudinal associations between serum uric acid and metabolic syndrome. Endocrine 2012, 4:450-457.
    • (2012) Endocrine , vol.4 , pp. 450-457
    • Gonçalves, J.P.1    Oliveira, A.2    Severo, M.3
  • 78
    • 84856102284 scopus 로고    scopus 로고
    • High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population
    • Hara S., Tsuji H., Ohmoto Y., et al. High serum uric acid level and low urine pH as predictors of metabolic syndrome: a retrospective cohort study in a Japanese urban population. Metabolism: Clinical and Experimental 2012, 61:281-288.
    • (2012) Metabolism: Clinical and Experimental , vol.61 , pp. 281-288
    • Hara, S.1    Tsuji, H.2    Ohmoto, Y.3
  • 79
    • 84872337728 scopus 로고    scopus 로고
    • Serum uric acid and appropriate cut-off value for prediction of metabolic syndrome among Chinese adults
    • Zhang M.L., Gao Y.X., Wang X., et al. Serum uric acid and appropriate cut-off value for prediction of metabolic syndrome among Chinese adults. Journal of Clinical Biochemistry and Nutrition 2013, 52:38-42.
    • (2013) Journal of Clinical Biochemistry and Nutrition , vol.52 , pp. 38-42
    • Zhang, M.L.1    Gao, Y.X.2    Wang, X.3
  • 80
    • 84877830243 scopus 로고    scopus 로고
    • Serum uric acid predicts both current and future components of the metabolic syndrome
    • Osgood K., Krakoff J., Thearle M. Serum uric acid predicts both current and future components of the metabolic syndrome. Metabolic Syndrome and Related Disorders 2013, 11:157-162.
    • (2013) Metabolic Syndrome and Related Disorders , vol.11 , pp. 157-162
    • Osgood, K.1    Krakoff, J.2    Thearle, M.3
  • 81
    • 84875073142 scopus 로고    scopus 로고
    • Association between uric acid and metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran
    • Ziaee A., Esmailzadehha N., Ghorbani A., et al. Association between uric acid and metabolic syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran. Global Journal of Health Science 2012, 5:155-165.
    • (2012) Global Journal of Health Science , vol.5 , pp. 155-165
    • Ziaee, A.1    Esmailzadehha, N.2    Ghorbani, A.3
  • 82
    • 84870754237 scopus 로고    scopus 로고
    • Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel
    • Cohen E., Krause I., Fraser A., et al. Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel. Israel Medical Association Journal 2012, 14:676-680.
    • (2012) Israel Medical Association Journal , vol.14 , pp. 676-680
    • Cohen, E.1    Krause, I.2    Fraser, A.3
  • 83
    • 43049170503 scopus 로고    scopus 로고
    • Fructose consumption as a risk factor for non-alcoholic fatty liver disease
    • Ouyang X., Cirillo P., Sautin Y., et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. Journal of Hepatology 2008, 48:993-999.
    • (2008) Journal of Hepatology , vol.48 , pp. 993-999
    • Ouyang, X.1    Cirillo, P.2    Sautin, Y.3
  • 84
    • 77952692915 scopus 로고    scopus 로고
    • Increased fructose consumption is associated with fibrosis severity in patients with non-alcoholic fatty liver disease
    • Abdelmalek M.F., Suzuki A., Guy C., et al. Increased fructose consumption is associated with fibrosis severity in patients with non-alcoholic fatty liver disease. Hepatology 2010, 51:1961-1971.
    • (2010) Hepatology , vol.51 , pp. 1961-1971
    • Abdelmalek, M.F.1    Suzuki, A.2    Guy, C.3
  • 86
    • 34548396882 scopus 로고    scopus 로고
    • Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community
    • Dhingra R., Sullivan L., Jacques P.F., et al. Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community. Circulation 2007, 116:480-488.
    • (2007) Circulation , vol.116 , pp. 480-488
    • Dhingra, R.1    Sullivan, L.2    Jacques, P.F.3
  • 87
    • 77949541626 scopus 로고    scopus 로고
    • Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response
    • Perez-Pozo S.E., Schold J., Nakagawa T., et al. Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response. International Journal of Obesity 2010, 34:454-461.
    • (2010) International Journal of Obesity , vol.34 , pp. 454-461
    • Perez-Pozo, S.E.1    Schold, J.2    Nakagawa, T.3
  • 88
    • 84878720152 scopus 로고    scopus 로고
    • Fructose: a key factor in the development of metabolic syndrome and hypertension
    • Khitan Z., Kim D.H. Fructose: a key factor in the development of metabolic syndrome and hypertension. Journal of Nutrition and Metabolism 2013, 2013:682673.
    • (2013) Journal of Nutrition and Metabolism , vol.2013 , pp. 682673
    • Khitan, Z.1    Kim, D.H.2
  • 90
    • 84861968652 scopus 로고    scopus 로고
    • Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania
    • Ittermann T., Haring R., Wallaschofski H., et al. Inverse association between serum free thyroxine levels and hepatic steatosis: results from the Study of Health in Pomerania. Thyroid 2012, 22:568-574.
    • (2012) Thyroid , vol.22 , pp. 568-574
    • Ittermann, T.1    Haring, R.2    Wallaschofski, H.3
  • 91
    • 84862704765 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease across the spectrum of hypothyroidism
    • Chung G.E., Kim D., Kim W., et al. Non-alcoholic fatty liver disease across the spectrum of hypothyroidism. Journal of Hepatology 2012, 57:150-156.
    • (2012) Journal of Hepatology , vol.57 , pp. 150-156
    • Chung, G.E.1    Kim, D.2    Kim, W.3
  • 92
    • 84878323948 scopus 로고    scopus 로고
    • Is non-alcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?
    • Carulli L., Ballestri S., Lonardo A., et al. Is non-alcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?. Internal and Emergency Medicine 2013, 8:297-305.
    • (2013) Internal and Emergency Medicine , vol.8 , pp. 297-305
    • Carulli, L.1    Ballestri, S.2    Lonardo, A.3
  • 93
    • 63049085136 scopus 로고    scopus 로고
    • Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women
    • Park H.T., Cho G.J., Ahn K.H., et al. Thyroid stimulating hormone is associated with metabolic syndrome in euthyroid postmenopausal women. Maturitas 2009, 62:301-305.
    • (2009) Maturitas , vol.62 , pp. 301-305
    • Park, H.T.1    Cho, G.J.2    Ahn, K.H.3
  • 94
    • 77950205510 scopus 로고    scopus 로고
    • A high normal TSH is associated with the metabolic syndrome
    • Ruhla S., Weickert M.O., Arafat A.M., et al. A high normal TSH is associated with the metabolic syndrome. Clinical Endocrinology 2010, 72:696-701.
    • (2010) Clinical Endocrinology , vol.72 , pp. 696-701
    • Ruhla, S.1    Weickert, M.O.2    Arafat, A.M.3
  • 95
    • 79251621005 scopus 로고    scopus 로고
    • The relationship between serum thyrotropin and components of metabolic syndrome
    • Lai Y., Wang J., Jiang F., et al. The relationship between serum thyrotropin and components of metabolic syndrome. Endocrine Journal 2011, 58:23-30.
    • (2011) Endocrine Journal , vol.58 , pp. 23-30
    • Lai, Y.1    Wang, J.2    Jiang, F.3
  • 97
    • 84860180775 scopus 로고    scopus 로고
    • Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study
    • Waring A.C., Rodondi N., Harrison S., et al. Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study. Clinical Endocrinology 2012, 76:911.
    • (2012) Clinical Endocrinology , vol.76 , pp. 911
    • Waring, A.C.1    Rodondi, N.2    Harrison, S.3
  • 98
    • 77952561299 scopus 로고    scopus 로고
    • Bile acids as regulators of hepatic lipid and glucose metabolism
    • Trauner M., Claudel T., Fickert P., et al. Bile acids as regulators of hepatic lipid and glucose metabolism. Digestive Diseases 2010, 28:220-224.
    • (2010) Digestive Diseases , vol.28 , pp. 220-224
    • Trauner, M.1    Claudel, T.2    Fickert, P.3
  • 101
    • 80051520866 scopus 로고    scopus 로고
    • Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome
    • Liaset B., Hao Q., Jørgensen H., et al. Nutritional regulation of bile acid metabolism is associated with improved pathological characteristics of the metabolic syndrome. Journal of Biological Chemistry 2011, 286:28382-28395.
    • (2011) Journal of Biological Chemistry , vol.286 , pp. 28382-28395
    • Liaset, B.1    Hao, Q.2    Jørgensen, H.3
  • 102
    • 84865603263 scopus 로고    scopus 로고
    • Bile acid binding resin improves metabolic control through the induction of energy expenditure
    • Watanabe M., Morimoto K., Houten S.M., et al. Bile acid binding resin improves metabolic control through the induction of energy expenditure. PLoS ONE 2012, 7:e38286.
    • (2012) PLoS ONE , vol.7 , pp. e38286
    • Watanabe, M.1    Morimoto, K.2    Houten, S.M.3
  • 103
    • 84864861866 scopus 로고    scopus 로고
    • Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease
    • Porez G., Prawitt J., Gross B., et al. Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease. Journal of Lipid Research 2012, 53:1723-1737.
    • (2012) Journal of Lipid Research , vol.53 , pp. 1723-1737
    • Porez, G.1    Prawitt, J.2    Gross, B.3
  • 104
    • 77954235797 scopus 로고    scopus 로고
    • Fitness versus fatness: moving beyond weight loss in non-alcoholic fatty liver disease
    • Johnson N.A., George J. Fitness versus fatness: moving beyond weight loss in non-alcoholic fatty liver disease. Hepatology 2010, 52:370-381.
    • (2010) Hepatology , vol.52 , pp. 370-381
    • Johnson, N.A.1    George, J.2
  • 105
    • 80051545931 scopus 로고    scopus 로고
    • Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss
    • Hallsworth K., Fattakhova G., Hollingsworth K.G., et al. Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss. Gut 2011, 60:1278-1283.
    • (2011) Gut , vol.60 , pp. 1278-1283
    • Hallsworth, K.1    Fattakhova, G.2    Hollingsworth, K.G.3
  • 106
    • 84867702046 scopus 로고    scopus 로고
    • Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults
    • Bae J.C., Suh S., Park S.E., et al. Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults. PLoS ONE 2012, 7:e46819.
    • (2012) PLoS ONE , vol.7 , pp. e46819
    • Bae, J.C.1    Suh, S.2    Park, S.E.3
  • 107
    • 84862700268 scopus 로고    scopus 로고
    • Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis
    • Keating S.E., Hackett D.A., George J., et al. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Journal of Hepatology 2012, 57:157-166.
    • (2012) Journal of Hepatology , vol.57 , pp. 157-166
    • Keating, S.E.1    Hackett, D.A.2    George, J.3
  • 108
    • 84866407037 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study
    • Gerber L., Otgonsuren M., Mishra A., et al. Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study. Alimentary Pharmacology and Therapeutics 2012, 36:772-781.
    • (2012) Alimentary Pharmacology and Therapeutics , vol.36 , pp. 772-781
    • Gerber, L.1    Otgonsuren, M.2    Mishra, A.3
  • 109
    • 83555176039 scopus 로고    scopus 로고
    • Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review
    • Thoma C., Day C.P., Trenell M.I. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. Journal of Hepatology 2012, 56:255-266.
    • (2012) Journal of Hepatology , vol.56 , pp. 255-266
    • Thoma, C.1    Day, C.P.2    Trenell, M.I.3
  • 110
    • 84870406456 scopus 로고    scopus 로고
    • Physical activity behaviour in patients with metabolic syndrome
    • Murer M., Schmied C., Battegay E., et al. Physical activity behaviour in patients with metabolic syndrome. Swiss Medical Weekly 2012, 142:w13691.
    • (2012) Swiss Medical Weekly , vol.142 , pp. w13691
    • Murer, M.1    Schmied, C.2    Battegay, E.3
  • 111
    • 84868684984 scopus 로고    scopus 로고
    • Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis
    • Yamaoka K., Tango T. Effects of lifestyle modification on metabolic syndrome: a systematic review and meta-analysis. BMC Medicine 2012, 10:138.
    • (2012) BMC Medicine , vol.10 , pp. 138
    • Yamaoka, K.1    Tango, T.2
  • 112
    • 84870545270 scopus 로고    scopus 로고
    • Reduction in metabolic syndrome among obese young men is associated with exercise-induced body composition changes during military service
    • Hagnäs M.P., Cederberg H., Mikkola I., et al. Reduction in metabolic syndrome among obese young men is associated with exercise-induced body composition changes during military service. Diabetes Research and Clinical Practice 2012, 98:312-319.
    • (2012) Diabetes Research and Clinical Practice , vol.98 , pp. 312-319
    • Hagnäs, M.P.1    Cederberg, H.2    Mikkola, I.3
  • 113
    • 84869787059 scopus 로고    scopus 로고
    • Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women
    • Kim J.W., Kim D.Y. Effects of aerobic exercise training on serum sex hormone binding globulin, body fat index, and metabolic syndrome factors in obese postmenopausal women. Metabolic Syndrome and Related Disorders 2012, 10:452-457.
    • (2012) Metabolic Syndrome and Related Disorders , vol.10 , pp. 452-457
    • Kim, J.W.1    Kim, D.Y.2
  • 114
    • 84864515458 scopus 로고    scopus 로고
    • Effect of six months lifestyle intervention in Japanese men with metabolic syndrome: randomized controlled trial
    • Nanri A., Tomita K., Matsushita Y., et al. Effect of six months lifestyle intervention in Japanese men with metabolic syndrome: randomized controlled trial. Journal of Occupational Health 2012, 54:215-222.
    • (2012) Journal of Occupational Health , vol.54 , pp. 215-222
    • Nanri, A.1    Tomita, K.2    Matsushita, Y.3
  • 115
  • 116
    • 84873028915 scopus 로고    scopus 로고
    • Lifestyle-based physical activity intervention for one year improves metabolic syndrome in overweight male employees
    • Kim J., Tanabe K., Yoshizawa Y., et al. Lifestyle-based physical activity intervention for one year improves metabolic syndrome in overweight male employees. Tohoku Journal of Experimental Medicine 2013, 229:11-17.
    • (2013) Tohoku Journal of Experimental Medicine , vol.229 , pp. 11-17
    • Kim, J.1    Tanabe, K.2    Yoshizawa, Y.3
  • 117
    • 46249090385 scopus 로고    scopus 로고
    • Modest wine drinking and decreased prevalence of suspected non-alcoholic fatty liver disease
    • Dunn W., Xu R., Schwimmer J.B. Modest wine drinking and decreased prevalence of suspected non-alcoholic fatty liver disease. Hepatology 2008, 47:1947-1954.
    • (2008) Hepatology , vol.47 , pp. 1947-1954
    • Dunn, W.1    Xu, R.2    Schwimmer, J.B.3
  • 118
    • 78650876710 scopus 로고    scopus 로고
    • Alcohol consumption appears to protect against non-alcoholic fatty liver disease
    • Moriya A., Iwasaki Y., Ohguchi S., et al. Alcohol consumption appears to protect against non-alcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 2011, 33:378-388.
    • (2011) Alimentary Pharmacology and Therapeutics , vol.33 , pp. 378-388
    • Moriya, A.1    Iwasaki, Y.2    Ohguchi, S.3
  • 119
    • 84863987868 scopus 로고    scopus 로고
    • Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD)
    • Dunn W., Sanyal A.J., Brunt E.M., et al. Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). Journal of Hepatology 2012, 57:384-391.
    • (2012) Journal of Hepatology , vol.57 , pp. 384-391
    • Dunn, W.1    Sanyal, A.J.2    Brunt, E.M.3
  • 120
    • 84856001236 scopus 로고    scopus 로고
    • Protective effect of alcohol consumption for fatty liver but not metabolic syndrome
    • Hamaguchi M., Kojima T., Ohbora A., et al. Protective effect of alcohol consumption for fatty liver but not metabolic syndrome. World Journal of Gastroenterology 2012, 18:156-167.
    • (2012) World Journal of Gastroenterology , vol.18 , pp. 156-167
    • Hamaguchi, M.1    Kojima, T.2    Ohbora, A.3
  • 121
    • 7444240186 scopus 로고    scopus 로고
    • Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001
    • Carnethon M.R., Loria C.M., Hill J.O., et al. Risk factors for the metabolic syndrome: the Coronary Artery Risk Development in Young Adults (CARDIA) study, 1985-2001. Diabetes Care 2004, 27:2707-2715.
    • (2004) Diabetes Care , vol.27 , pp. 2707-2715
    • Carnethon, M.R.1    Loria, C.M.2    Hill, J.O.3
  • 122
    • 34548839093 scopus 로고    scopus 로고
    • Lifestyle factors and incident metabolic syndrome. The Tromsø study 1979-2001
    • 217e24
    • Wilsgaard T., Jacobsen B.K. Lifestyle factors and incident metabolic syndrome. The Tromsø study 1979-2001. Diabetes Research and Clinical Practice 2007, 78:217e24.
    • (2007) Diabetes Research and Clinical Practice , vol.78
    • Wilsgaard, T.1    Jacobsen, B.K.2
  • 123
    • 43549111614 scopus 로고    scopus 로고
    • Prospective study of alcohol consumption and metabolic syndrome
    • Baik I., Shin C. Prospective study of alcohol consumption and metabolic syndrome. American Journal of Clinical Nutrition 2008, 87:1455-1463.
    • (2008) American Journal of Clinical Nutrition , vol.87 , pp. 1455-1463
    • Baik, I.1    Shin, C.2
  • 124
    • 67349260732 scopus 로고    scopus 로고
    • Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies
    • Alkerwi A., Boutsen M., Vaillant M., et al. Alcohol consumption and the prevalence of metabolic syndrome: a meta-analysis of observational studies. Atherosclerosis 2009, 204:624-635.
    • (2009) Atherosclerosis , vol.204 , pp. 624-635
    • Alkerwi, A.1    Boutsen, M.2    Vaillant, M.3
  • 125
    • 70449394764 scopus 로고    scopus 로고
    • Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis
    • Baliunas D.O., Taylor B.J., Irving H., et al. Alcohol as a risk factor for type 2 diabetes: a systematic review and meta-analysis. Diabetes Care 2009, 32:2123-2132.
    • (2009) Diabetes Care , vol.32 , pp. 2123-2132
    • Baliunas, D.O.1    Taylor, B.J.2    Irving, H.3
  • 126
    • 77955777500 scopus 로고    scopus 로고
    • Cross-sectional relationship between alcohol consumption and prevalence of metabolic syndrome in Japanese men and women
    • Wakabayashi I. Cross-sectional relationship between alcohol consumption and prevalence of metabolic syndrome in Japanese men and women. Journal of Atherosclerosis and Thrombosis 2010, 17:695-704.
    • (2010) Journal of Atherosclerosis and Thrombosis , vol.17 , pp. 695-704
    • Wakabayashi, I.1
  • 127
    • 79959547502 scopus 로고    scopus 로고
    • Alcohol-drinking patterns and metabolic syndrome risk: the 2007 Korean national health and nutrition examination survey
    • Lee K.W., Park B.J., Kang H.T., et al. Alcohol-drinking patterns and metabolic syndrome risk: the 2007 Korean national health and nutrition examination survey. Alcohol 2011, 45:499-505.
    • (2011) Alcohol , vol.45 , pp. 499-505
    • Lee, K.W.1    Park, B.J.2    Kang, H.T.3
  • 129
    • 84867855926 scopus 로고    scopus 로고
    • Alcohol consumption and incidence of metabolic syndrome in Korean men. A 3-year follow-up study
    • Kim B.J., Kim B.S., Kang J.H. Alcohol consumption and incidence of metabolic syndrome in Korean men. A 3-year follow-up study. Circulation Journal 2012, 76:2363-2371.
    • (2012) Circulation Journal , vol.76 , pp. 2363-2371
    • Kim, B.J.1    Kim, B.S.2    Kang, J.H.3
  • 130
    • 84862973918 scopus 로고    scopus 로고
    • The association of alcohol consumption with metabolic syndrome and its individual components: the Taichung community health study
    • Chen C.C., Lin W.Y., Li C.I., et al. The association of alcohol consumption with metabolic syndrome and its individual components: the Taichung community health study. Nutrition Research 2012, 32:24-29.
    • (2012) Nutrition Research , vol.32 , pp. 24-29
    • Chen, C.C.1    Lin, W.Y.2    Li, C.I.3
  • 131
    • 84883552004 scopus 로고    scopus 로고
    • Different types of alcoholic beverages and incidence of metabolic syndrome and its components in a Mediterranean cohort
    • Barrio-Lopez M.T., Bes-Rastrollo M., Sayon-Orea C., et al. Different types of alcoholic beverages and incidence of metabolic syndrome and its components in a Mediterranean cohort. Clinical Nutrition 2013, 32:797-804.
    • (2013) Clinical Nutrition , vol.32 , pp. 797-804
    • Barrio-Lopez, M.T.1    Bes-Rastrollo, M.2    Sayon-Orea, C.3
  • 132
    • 84882744078 scopus 로고    scopus 로고
    • Prospective study of alcohol consumption and the incidence of the metabolic syndrome in US men
    • Stoutenberg M., Lee D.C., Sui X., et al. Prospective study of alcohol consumption and the incidence of the metabolic syndrome in US men. British Journal of Nutrition 2013, 110:901-910.
    • (2013) British Journal of Nutrition , vol.110 , pp. 901-910
    • Stoutenberg, M.1    Lee, D.C.2    Sui, X.3
  • 134
    • 84856381801 scopus 로고    scopus 로고
    • Association of coffee and caffeine consumption with fatty liver disease, non-alcoholic steatohepatitis, and degree of hepatic fibrosis
    • Molloy J.W., Calcagno C.J., Williams C.D., et al. Association of coffee and caffeine consumption with fatty liver disease, non-alcoholic steatohepatitis, and degree of hepatic fibrosis. Hepatology 2012, 55:429-436.
    • (2012) Hepatology , vol.55 , pp. 429-436
    • Molloy, J.W.1    Calcagno, C.J.2    Williams, C.D.3
  • 135
    • 84867574518 scopus 로고    scopus 로고
    • Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery
    • Anty R., Marjoux S., Iannelli A., et al. Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery. Journal of Hepatology 2012, 57:1090-1096.
    • (2012) Journal of Hepatology , vol.57 , pp. 1090-1096
    • Anty, R.1    Marjoux, S.2    Iannelli, A.3
  • 136
    • 84859321517 scopus 로고    scopus 로고
    • High coffee intake is associated with lower grade non-alcoholic fatty liver disease: the role of peripheral antioxidant activity
    • Gutiérrez-Grobe Y., Chávez-Tapia N., Sánchez-Valle V., et al. High coffee intake is associated with lower grade non-alcoholic fatty liver disease: the role of peripheral antioxidant activity. Annals of Hepatology 2012, 11:350-355.
    • (2012) Annals of Hepatology , vol.11 , pp. 350-355
    • Gutiérrez-Grobe, Y.1    Chávez-Tapia, N.2    Sánchez-Valle, V.3
  • 138
    • 77958093867 scopus 로고    scopus 로고
    • Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach
    • Kalthoff S., Ehmer U., Freiberg N., et al. Coffee induces expression of glucuronosyltransferases by the aryl hydrocarbon receptor and Nrf2 in liver and stomach. Gastroenterology 2010, 139:1699-1710.
    • (2010) Gastroenterology , vol.139 , pp. 1699-1710
    • Kalthoff, S.1    Ehmer, U.2    Freiberg, N.3
  • 139
    • 77952148066 scopus 로고    scopus 로고
    • Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice
    • Yamauchi R., Kobayashi M., Matsuda Y., et al. Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice. Journal of Agricultural and Food Chemistry 2010, 58:5597-5603.
    • (2010) Journal of Agricultural and Food Chemistry , vol.58 , pp. 5597-5603
    • Yamauchi, R.1    Kobayashi, M.2    Matsuda, Y.3
  • 140
    • 84855266156 scopus 로고    scopus 로고
    • Coffee and caffeine improve insulin sensitivity and glucose tolerance in C57BL/6J mice fed a high-fat diet
    • Matsuda Y., Kobayashi M., Yamauchi R., et al. Coffee and caffeine improve insulin sensitivity and glucose tolerance in C57BL/6J mice fed a high-fat diet. Bioscience, Biotechnology, and Biochemistry 2011, 75:2309-2315.
    • (2011) Bioscience, Biotechnology, and Biochemistry , vol.75 , pp. 2309-2315
    • Matsuda, Y.1    Kobayashi, M.2    Yamauchi, R.3
  • 141
    • 84868223872 scopus 로고    scopus 로고
    • HEPAVIH Study Group. Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13)
    • Carrieri M.P., Sogni P., Cohen J., et al. HEPAVIH Study Group. Elevated coffee consumption and reduced risk of insulin resistance in HIV-HCV coinfected patients (HEPAVIH ANRS CO-13). Hepatology 2012, 56:2010.
    • (2012) Hepatology , vol.56 , pp. 2010
    • Carrieri, M.P.1    Sogni, P.2    Cohen, J.3
  • 142
    • 84866134174 scopus 로고    scopus 로고
    • Catechins and caffeine inhibit fat accumulation in mice through the improvement of hepatic lipid metabolism
    • Sugiura C., Nishimatsu S., Moriyama T., et al. Catechins and caffeine inhibit fat accumulation in mice through the improvement of hepatic lipid metabolism. Journal of Obesity 2012, 2012:520510.
    • (2012) Journal of Obesity , vol.2012 , pp. 520510
    • Sugiura, C.1    Nishimatsu, S.2    Moriyama, T.3
  • 143
    • 33947586969 scopus 로고    scopus 로고
    • Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population
    • Hino A., Adachi H., Enomoto M., et al. Habitual coffee but not green tea consumption is inversely associated with metabolic syndrome: an epidemiological study in a general Japanese population. Diabetes Research and Clinical Practice 2007, 76:383-389.
    • (2007) Diabetes Research and Clinical Practice , vol.76 , pp. 383-389
    • Hino, A.1    Adachi, H.2    Enomoto, M.3
  • 144
    • 84865444143 scopus 로고    scopus 로고
    • Caffeine attenuates metabolic syndrome in diet-induced obese rats
    • Panchal S.K., Wong W.Y., Kauter K., et al. Caffeine attenuates metabolic syndrome in diet-induced obese rats. Nutrition 2012, 28:1055-1062.
    • (2012) Nutrition , vol.28 , pp. 1055-1062
    • Panchal, S.K.1    Wong, W.Y.2    Kauter, K.3
  • 145
    • 84874676639 scopus 로고    scopus 로고
    • Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan
    • Takami H., Nakamoto M., Uemura H., et al. Inverse correlation between coffee consumption and prevalence of metabolic syndrome: baseline survey of the Japan Multi-Institutional Collaborative Cohort (J-MICC) Study in Tokushima, Japan. Journal of Epidemiology 2013, 23:12-20.
    • (2013) Journal of Epidemiology , vol.23 , pp. 12-20
    • Takami, H.1    Nakamoto, M.2    Uemura, H.3
  • 146
    • 79960215555 scopus 로고    scopus 로고
    • Impact of cigarette smoking on onset of non-alcoholic fatty liver disease over a 10-year period
    • Hamabe A., Uto H., Imamura Y., et al. Impact of cigarette smoking on onset of non-alcoholic fatty liver disease over a 10-year period. Journal of Gastroenterology 2011, 46:769-778.
    • (2011) Journal of Gastroenterology , vol.46 , pp. 769-778
    • Hamabe, A.1    Uto, H.2    Imamura, Y.3
  • 147
    • 79952701706 scopus 로고    scopus 로고
    • Non-alcoholic steatohepatitis clinical research network. Smoking and severity of hepatic fibrosis in non-alcoholic fatty liver disease
    • Zein C.O., Unalp A., Colvin R., et al. Non-alcoholic steatohepatitis clinical research network. Smoking and severity of hepatic fibrosis in non-alcoholic fatty liver disease. Journal of Hepatology 2011, 54:753-759.
    • (2011) Journal of Hepatology , vol.54 , pp. 753-759
    • Zein, C.O.1    Unalp, A.2    Colvin, R.3
  • 148
    • 84869224505 scopus 로고    scopus 로고
    • Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study
    • Koehler E.M., Schouten J.N., Hansen B.E., et al. Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study. Journal of Hepatology 2012, 57:1305-1311.
    • (2012) Journal of Hepatology , vol.57 , pp. 1305-1311
    • Koehler, E.M.1    Schouten, J.N.2    Hansen, B.E.3
  • 149
    • 84867636147 scopus 로고    scopus 로고
    • Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies
    • Sun K., Liu J., Ning G. Active smoking and risk of metabolic syndrome: a meta-analysis of prospective studies. PLoS ONE 2012, 7:e47791.
    • (2012) PLoS ONE , vol.7 , pp. e47791
    • Sun, K.1    Liu, J.2    Ning, G.3
  • 150
    • 80455168028 scopus 로고    scopus 로고
    • Association of short sleep duration with obesity, diabetes, fatty liver and behavioral factors in Japanese men
    • Hsieh S.D., Muto T., Murase T., et al. Association of short sleep duration with obesity, diabetes, fatty liver and behavioral factors in Japanese men. Internal Medicine 2011, 50:2499-2502.
    • (2011) Internal Medicine , vol.50 , pp. 2499-2502
    • Hsieh, S.D.1    Muto, T.2    Murase, T.3
  • 151
    • 83555176096 scopus 로고    scopus 로고
    • Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese
    • Aron-Wisnewsky J., Minville C., Tordjman J., et al. Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease in morbid obese. Journal of Hepatology 2012, 56:225-233.
    • (2012) Journal of Hepatology , vol.56 , pp. 225-233
    • Aron-Wisnewsky, J.1    Minville, C.2    Tordjman, J.3
  • 152
    • 84876473298 scopus 로고    scopus 로고
    • Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis
    • Musso G., Cassader M., Olivetti C., et al. Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis. Obesity Reviews 2013, 14:417-431.
    • (2013) Obesity Reviews , vol.14 , pp. 417-431
    • Musso, G.1    Cassader, M.2    Olivetti, C.3
  • 153
    • 33846995052 scopus 로고    scopus 로고
    • Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation
    • Sookoian S., Gemma C., Fernández Gianotti T., et al. Effects of rotating shift work on biomarkers of metabolic syndrome and inflammation. Journal of Internal Medicine 2007, 261:285-292.
    • (2007) Journal of Internal Medicine , vol.261 , pp. 285-292
    • Sookoian, S.1    Gemma, C.2    Fernández Gianotti, T.3
  • 154
    • 77954471399 scopus 로고    scopus 로고
    • A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects
    • Donga E., van Dijk M., van Dijk J.G., et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. Journal of Clinical Endocrinology and Metabolism 2010, 95:2963-2968.
    • (2010) Journal of Clinical Endocrinology and Metabolism , vol.95 , pp. 2963-2968
    • Donga, E.1    van Dijk, M.2    van Dijk, J.G.3
  • 155
    • 84867202413 scopus 로고    scopus 로고
    • Association between short sleep duration and high incidence of metabolic syndrome in midlife women
    • Choi J.K., Kim M.Y., Kim J.K., et al. Association between short sleep duration and high incidence of metabolic syndrome in midlife women. Tohoku Journal of Experimental Medicine 2011, 225:187-193.
    • (2011) Tohoku Journal of Experimental Medicine , vol.225 , pp. 187-193
    • Choi, J.K.1    Kim, M.Y.2    Kim, J.K.3
  • 156
    • 84860801434 scopus 로고    scopus 로고
    • Self-reported long total sleep duration is associated with metabolic syndrome: the Guangzhou Biobank Cohort Study
    • Arora T., Jiang C.Q., Thomas G.N., et al. Self-reported long total sleep duration is associated with metabolic syndrome: the Guangzhou Biobank Cohort Study. Diabetes Care 2011, 34:2317-2319.
    • (2011) Diabetes Care , vol.34 , pp. 2317-2319
    • Arora, T.1    Jiang, C.Q.2    Thomas, G.N.3
  • 157
    • 79959961564 scopus 로고    scopus 로고
    • Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans
    • Yilmaz Y., Ones T., Purnak T., et al. Association between the presence of brown adipose tissue and non-alcoholic fatty liver disease in adult humans. Alimentary Pharmacology and Therapeutics 2011, 34:318-323.
    • (2011) Alimentary Pharmacology and Therapeutics , vol.34 , pp. 318-323
    • Yilmaz, Y.1    Ones, T.2    Purnak, T.3
  • 159
    • 64349105205 scopus 로고    scopus 로고
    • Identification and importance of brown adipose tissue in adult humans
    • Cypess A.M., Lehman S., Williams G., et al. Identification and importance of brown adipose tissue in adult humans. New England Journal of Medicine 2009, 360:1509-1517.
    • (2009) New England Journal of Medicine , vol.360 , pp. 1509-1517
    • Cypess, A.M.1    Lehman, S.2    Williams, G.3
  • 161
    • 84878199366 scopus 로고    scopus 로고
    • In uncontrolled diabetes, thyroid hormone and sympathetic activators induce thermogenesis without increasing glucose uptake in brown adipose tissue
    • Matsen M.E., Thaler J.P., Wisse B.E., et al. In uncontrolled diabetes, thyroid hormone and sympathetic activators induce thermogenesis without increasing glucose uptake in brown adipose tissue. American Journal of Physiology: Endocrinology and Metabolism 2013, 304:E734-E746.
    • (2013) American Journal of Physiology: Endocrinology and Metabolism , vol.304 , pp. E734-E746
    • Matsen, M.E.1    Thaler, J.P.2    Wisse, B.E.3
  • 162
    • 0035125052 scopus 로고    scopus 로고
    • The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis
    • Wigg A.J., Roberts-Thomson I.C., Dymock R.B., et al. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001, 48:206-211.
    • (2001) Gut , vol.48 , pp. 206-211
    • Wigg, A.J.1    Roberts-Thomson, I.C.2    Dymock, R.B.3
  • 163
    • 0035045382 scopus 로고    scopus 로고
    • Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of non-alcoholic steatohepatitis
    • Nair S., Cope K., Risby T.H., et al. Obesity and female gender increase breath ethanol concentration: potential implications for the pathogenesis of non-alcoholic steatohepatitis. American Journal of Gastroenterology 2001, 96:1200-1204.
    • (2001) American Journal of Gastroenterology , vol.96 , pp. 1200-1204
    • Nair, S.1    Cope, K.2    Risby, T.H.3
  • 164
    • 49449083979 scopus 로고    scopus 로고
    • Non-alcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake
    • Thuy S., Ladurner R., Volynets V., et al. Non-alcoholic fatty liver disease in humans is associated with increased plasma endotoxin and plasminogen activator inhibitor 1 concentrations and with fructose intake. Journal of Nutrition 2008, 138:1452-1455.
    • (2008) Journal of Nutrition , vol.138 , pp. 1452-1455
    • Thuy, S.1    Ladurner, R.2    Volynets, V.3
  • 165
    • 68949148889 scopus 로고    scopus 로고
    • Increased intestinal permeability and tight junction alterations in non-alcoholic fatty liver disease
    • Miele L., Valenza V., La Torre G., et al. Increased intestinal permeability and tight junction alterations in non-alcoholic fatty liver disease. Hepatology 2009, 49:1877-1887.
    • (2009) Hepatology , vol.49 , pp. 1877-1887
    • Miele, L.1    Valenza, V.2    La Torre, G.3
  • 166
    • 77950419928 scopus 로고    scopus 로고
    • Elevated endotoxin levels in non-alcoholic fatty liver disease
    • Harte A.L., da Silva N.F., Creely S.J., et al. Elevated endotoxin levels in non-alcoholic fatty liver disease. Journal of Inflammation 2010, 7:15.
    • (2010) Journal of Inflammation , vol.7 , pp. 15
    • Harte, A.L.1    da Silva, N.F.2    Creely, S.J.3
  • 167
    • 78951470255 scopus 로고    scopus 로고
    • Novel evidence for chronic exposure to endotoxin in human non-alcoholic steatohepatitis
    • Verdam F.J., Rensen S.S., Driessen A., et al. Novel evidence for chronic exposure to endotoxin in human non-alcoholic steatohepatitis. Journal of Clinical Gastroenterology 2011, 45:149-152.
    • (2011) Journal of Clinical Gastroenterology , vol.45 , pp. 149-152
    • Verdam, F.J.1    Rensen, S.S.2    Driessen, A.3
  • 168
    • 84856957894 scopus 로고    scopus 로고
    • Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
    • Henao-Mejia J., Elinav E., Jin C., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
    • (2012) Nature , vol.482 , pp. 179-185
    • Henao-Mejia, J.1    Elinav, E.2    Jin, C.3
  • 169
    • 84862017188 scopus 로고    scopus 로고
    • Gut microbiota and non-alcoholic fatty liver disease
    • Machado M.V., Cortez-Pinto H. Gut microbiota and non-alcoholic fatty liver disease. Annals of Hepatology 2012, 11:440-449.
    • (2012) Annals of Hepatology , vol.11 , pp. 440-449
    • Machado, M.V.1    Cortez-Pinto, H.2
  • 170
    • 84866168894 scopus 로고    scopus 로고
    • Functional interactions between the gut microbiota and host metabolism
    • Tremaroli V., Bäckhed F. Functional interactions between the gut microbiota and host metabolism. Nature 2012, 489:242-249.
    • (2012) Nature , vol.489 , pp. 242-249
    • Tremaroli, V.1    Bäckhed, F.2
  • 171
    • 84873296091 scopus 로고    scopus 로고
    • Characterization of gut microbiomes in non-alcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH
    • Zhu L., Baker S.S., Gill C., et al. Characterization of gut microbiomes in non-alcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 2013, 57:601-609.
    • (2013) Hepatology , vol.57 , pp. 601-609
    • Zhu, L.1    Baker, S.S.2    Gill, C.3
  • 174
    • 33845874101 scopus 로고    scopus 로고
    • An obesity-associated gut microbiome with increased capacity for energy harvest
    • Turnbaugh P.J., Ley R.E., Mahowald M.A., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1031.
    • (2006) Nature , vol.444 , pp. 1027-1031
    • Turnbaugh, P.J.1    Ley, R.E.2    Mahowald, M.A.3
  • 175
    • 33845901507 scopus 로고    scopus 로고
    • Microbial ecology: human gut microbes associated with obesity
    • Ley R.E., Turnbaugh P.J., Klein S., et al. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
    • (2006) Nature , vol.444 , pp. 1022-1023
    • Ley, R.E.1    Turnbaugh, P.J.2    Klein, S.3
  • 176
    • 58749112734 scopus 로고    scopus 로고
    • A core gut microbiome in obese and lean twins
    • Turnbaugh P.J., Hamady M., Yatsunenko T., et al. A core gut microbiome in obese and lean twins. Nature 2009, 457:480-484.
    • (2009) Nature , vol.457 , pp. 480-484
    • Turnbaugh, P.J.1    Hamady, M.2    Yatsunenko, T.3
  • 177
    • 73949137604 scopus 로고    scopus 로고
    • Microbiota and SCFA in lean and overweight healthy subjects
    • Schwiertz A., Taras D., Schäfer K., et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010, 18:190-195.
    • (2010) Obesity , vol.18 , pp. 190-195
    • Schwiertz, A.1    Taras, D.2    Schäfer, K.3
  • 178
    • 65249099918 scopus 로고    scopus 로고
    • Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability
    • Cani P.D., Possemiers S., Van de Wiele T., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009, 58:1091-1103.
    • (2009) Gut , vol.58 , pp. 1091-1103
    • Cani, P.D.1    Possemiers, S.2    Van de Wiele, T.3
  • 179
    • 78650037263 scopus 로고    scopus 로고
    • Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers
    • Furet J.P., Kong L.C., Tap J., et al. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes 2010, 59:3049-3057.
    • (2010) Diabetes , vol.59 , pp. 3049-3057
    • Furet, J.P.1    Kong, L.C.2    Tap, J.3
  • 180
    • 77950250064 scopus 로고    scopus 로고
    • Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5
    • Vijay-Kumar M., Aitken J.D., Carvalho F.A., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010, 328:228-231.
    • (2010) Science , vol.328 , pp. 228-231
    • Vijay-Kumar, M.1    Aitken, J.D.2    Carvalho, F.A.3
  • 181
    • 79957902145 scopus 로고    scopus 로고
    • Gut microbiome, obesity, and metabolic dysfunction
    • Tilg H., Kaser A. Gut microbiome, obesity, and metabolic dysfunction. Journal of Clinical Investigation 2011, 121:2126-2132.
    • (2011) Journal of Clinical Investigation , vol.121 , pp. 2126-2132
    • Tilg, H.1    Kaser, A.2
  • 183
    • 84867096233 scopus 로고    scopus 로고
    • The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study
    • Leber B., Tripolt N.J., Blattl D., et al. The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study. European Journal of Clinical Nutrition 2012, 66:1110-1115.
    • (2012) European Journal of Clinical Nutrition , vol.66 , pp. 1110-1115
    • Leber, B.1    Tripolt, N.J.2    Blattl, D.3
  • 185
    • 84865055757 scopus 로고    scopus 로고
    • Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome
    • Zupancic M.L., Cantarel B.L., Liu Z., et al. Analysis of the gut microbiota in the old order Amish and its relation to the metabolic syndrome. PLoS ONE 2012, 7:e43052.
    • (2012) PLoS ONE , vol.7 , pp. e43052
    • Zupancic, M.L.1    Cantarel, B.L.2    Liu, Z.3
  • 186
    • 84866738529 scopus 로고    scopus 로고
    • Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome
    • Vrieze A., Van Nood E., Holleman F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143:913-916.
    • (2012) Gastroenterology , vol.143 , pp. 913-916
    • Vrieze, A.1    Van Nood, E.2    Holleman, F.3
  • 187
    • 84856715883 scopus 로고    scopus 로고
    • Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats
    • Parnell J.A., Reimer R.A. Prebiotic fibres dose-dependently increase satiety hormones and alter Bacteroidetes and Firmicutes in lean and obese JCR:LA-cp rats. British Journal of Nutrition 2012, 107:601-613.
    • (2012) British Journal of Nutrition , vol.107 , pp. 601-613
    • Parnell, J.A.1    Reimer, R.A.2
  • 188
    • 84875165515 scopus 로고    scopus 로고
    • The role of gut microbiota on insulin resistance
    • Caricilli A.M., Saad M.J. The role of gut microbiota on insulin resistance. Nutrients 2013, 5:829-851.
    • (2013) Nutrients , vol.5 , pp. 829-851
    • Caricilli, A.M.1    Saad, M.J.2
  • 189
    • 34547485376 scopus 로고    scopus 로고
    • Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease
    • Targher G., Bertolini L., Scala L., et al. Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases 2007, 17:517-524.
    • (2007) Nutrition, Metabolism and Cardiovascular Diseases , vol.17 , pp. 517-524
    • Targher, G.1    Bertolini, L.2    Scala, L.3
  • 190
    • 84870563131 scopus 로고    scopus 로고
    • Liver vitamin D receptor. CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with non-alcoholic steatohepatitis or hepatitis C virus
    • Barchetta I., Carotti S., Labbadia G., et al. Liver vitamin D receptor. CYP2R1, and CYP27A1 expression: relationship with liver histology and vitamin D3 levels in patients with non-alcoholic steatohepatitis or hepatitis C virus. Hepatology 2012, 56:2180-2187.
    • (2012) Hepatology , vol.56 , pp. 2180-2187
    • Barchetta, I.1    Carotti, S.2    Labbadia, G.3
  • 192
    • 84873312029 scopus 로고    scopus 로고
    • Association between liver-specific gene polymorphisms and their expression levels with non-alcoholic fatty liver disease
    • Adams L.A., White S.W., Marsh J.A., et al. Association between liver-specific gene polymorphisms and their expression levels with non-alcoholic fatty liver disease. Hepatology 2013, 57:590-600.
    • (2013) Hepatology , vol.57 , pp. 590-600
    • Adams, L.A.1    White, S.W.2    Marsh, J.A.3
  • 193
    • 80755148657 scopus 로고    scopus 로고
    • Prospective associations of vitamin D with b-cell function and glycemia
    • Kayaniyil S., Retnakaran R., Harris S.B., et al. Prospective associations of vitamin D with b-cell function and glycemia. Diabetes 2011, 60:2947-2953.
    • (2011) Diabetes , vol.60 , pp. 2947-2953
    • Kayaniyil, S.1    Retnakaran, R.2    Harris, S.B.3
  • 195
    • 84872831376 scopus 로고    scopus 로고
    • Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. adults: National Health and Nutrition Examination Surveys 2003-2006
    • Maki K.C., Fulgoni V.L., Keast D.R., et al. Vitamin D intake and status are associated with lower prevalence of metabolic syndrome in U.S. adults: National Health and Nutrition Examination Surveys 2003-2006. Metabolic Syndrome and Related Disorders 2012, 10:363-372.
    • (2012) Metabolic Syndrome and Related Disorders , vol.10 , pp. 363-372
    • Maki, K.C.1    Fulgoni, V.L.2    Keast, D.R.3
  • 196
    • 84879401158 scopus 로고    scopus 로고
    • Role of vitamin D in cardiometabolic diseases
    • Wang C. Role of vitamin D in cardiometabolic diseases. Journal of Diabetes Research 2013, 243934.
    • (2013) Journal of Diabetes Research , pp. 243934
    • Wang, C.1
  • 197
    • 84872865426 scopus 로고    scopus 로고
    • Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies
    • Khan H., Kunutsor S., Franco O.H., et al. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and meta-analysis of prospective studies. Proceedings of the Nutrition Society 2013, 72:89-97.
    • (2013) Proceedings of the Nutrition Society , vol.72 , pp. 89-97
    • Khan, H.1    Kunutsor, S.2    Franco, O.H.3
  • 198
    • 84896764742 scopus 로고    scopus 로고
    • Prospective association of 25(OH)D with metabolic syndrome
    • Kayaniyil S., Harris S.B., Retnakaran R., et al. Prospective association of 25(OH)D with metabolic syndrome. Clinical Endocrinology 2014, 80:502-507.
    • (2014) Clinical Endocrinology , vol.80 , pp. 502-507
    • Kayaniyil, S.1    Harris, S.B.2    Retnakaran, R.3
  • 199
    • 84876673360 scopus 로고    scopus 로고
    • Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment - an evolutionary perspective
    • Tsatsoulis A., Mantzaris M.D., Bellou S., et al. Insulin resistance: an adaptive mechanism becomes maladaptive in the current environment - an evolutionary perspective. Metabolism: Clinical and Experimental 2012, 62:622-633.
    • (2012) Metabolism: Clinical and Experimental , vol.62 , pp. 622-633
    • Tsatsoulis, A.1    Mantzaris, M.D.2    Bellou, S.3
  • 200
    • 34249650125 scopus 로고    scopus 로고
    • Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences
    • Leclercq I.A., Da Silva Morais A., Schroyen B., et al. Insulin resistance in hepatocytes and sinusoidal liver cells: mechanisms and consequences. Journal of Hepatology 2007, 47:142-156.
    • (2007) Journal of Hepatology , vol.47 , pp. 142-156
    • Leclercq, I.A.1    Da Silva Morais, A.2    Schroyen, B.3
  • 201
    • 84864198388 scopus 로고    scopus 로고
    • A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches
    • Seki E., Brenner D.A., Karin M. A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approaches. Gastroenterology 2012, 143:307-320.
    • (2012) Gastroenterology , vol.143 , pp. 307-320
    • Seki, E.1    Brenner, D.A.2    Karin, M.3
  • 202
    • 77950343252 scopus 로고    scopus 로고
    • Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
    • Hotamisligil G.S. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 2010, 140:900-917.
    • (2010) Cell , vol.140 , pp. 900-917
    • Hotamisligil, G.S.1
  • 203
    • 0024160877 scopus 로고
    • Banting lecture 1988: role of insulin resistance in human disease
    • Reaven G.M. Banting lecture 1988: role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
    • (1988) Diabetes , vol.37 , pp. 1595-1607
    • Reaven, G.M.1
  • 205
    • 20444467246 scopus 로고    scopus 로고
    • Should non-alcoholic fatty liver disease be renamed?
    • Loria P., Lonardo A., Carulli N. Should non-alcoholic fatty liver disease be renamed?. Digestive Diseases 2005, 23:72-82.
    • (2005) Digestive Diseases , vol.23 , pp. 72-82
    • Loria, P.1    Lonardo, A.2    Carulli, N.3
  • 206
    • 84859345557 scopus 로고    scopus 로고
    • Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome
    • Hamaguchi M., Takeda N., Kojima T., et al. Identification of individuals with non-alcoholic fatty liver disease by the diagnostic criteria for the metabolic syndrome. World Journal of Gastroenterology 2012, 18:1508-1516.
    • (2012) World Journal of Gastroenterology , vol.18 , pp. 1508-1516
    • Hamaguchi, M.1    Takeda, N.2    Kojima, T.3
  • 207
    • 79954548597 scopus 로고    scopus 로고
    • Insulin resistance in non-alcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?
    • Lonardo A., Bellentani S., Ratziu V., et al. Insulin resistance in non-alcoholic steatohepatitis: necessary but not sufficient - death of a dogma from analysis of therapeutic studies?. Expert Review of Gastroenterology & Hepatology 2011, 5:279-289.
    • (2011) Expert Review of Gastroenterology & Hepatology , vol.5 , pp. 279-289
    • Lonardo, A.1    Bellentani, S.2    Ratziu, V.3
  • 208
    • 11244308124 scopus 로고    scopus 로고
    • Chronological development of elevated aminotransferases in a non-alcoholic population
    • Suzuki A., Angulo P., Lymp J., et al. Chronological development of elevated aminotransferases in a non-alcoholic population. Hepatology 2005, 41:64-71.
    • (2005) Hepatology , vol.41 , pp. 64-71
    • Suzuki, A.1    Angulo, P.2    Lymp, J.3
  • 209
    • 30944455145 scopus 로고    scopus 로고
    • Insulin resistance: a metabolic pathway to chronic liver disease
    • Bugianesi E., McCullough A.J., Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005, 42:987-1000.
    • (2005) Hepatology , vol.42 , pp. 987-1000
    • Bugianesi, E.1    McCullough, A.J.2    Marchesini, G.3
  • 211
    • 34250356015 scopus 로고    scopus 로고
    • Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with non-alcoholic steatohepatitis
    • Yamaguchi K., Yang L., McCall S., et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with non-alcoholic steatohepatitis. Hepatology 2007, 45:1366-1374.
    • (2007) Hepatology , vol.45 , pp. 1366-1374
    • Yamaguchi, K.1    Yang, L.2    McCall, S.3
  • 212
    • 0002390372 scopus 로고    scopus 로고
    • Insulin resistance in non-alcoholic fatty liver disease: a clinical perspective
    • Kluwer, Dordrecht, The Netherlands, U. Leuschner, O. James, H. Dancygier (Eds.)
    • Lonardo A., Loria P., Carulli N. Insulin resistance in non-alcoholic fatty liver disease: a clinical perspective. Falk symposium 121 steatohepatitis (NASH and ASH) 2001, 104-113. Kluwer, Dordrecht, The Netherlands. U. Leuschner, O. James, H. Dancygier (Eds.).
    • (2001) Falk symposium 121 steatohepatitis (NASH and ASH) , pp. 104-113
    • Lonardo, A.1    Loria, P.2    Carulli, N.3
  • 213
    • 34249818502 scopus 로고    scopus 로고
    • Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?
    • Caldwell S.H., Ikura Y., Iezzoni J.C., et al. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?. Journal of Gastroenterology and Hepatology 2007, 22:S11-S19.
    • (2007) Journal of Gastroenterology and Hepatology , vol.22 , pp. S11-S19
    • Caldwell, S.H.1    Ikura, Y.2    Iezzoni, J.C.3
  • 214
    • 79959517565 scopus 로고    scopus 로고
    • Human fatty liver disease: old questions and new insights
    • Cohen J.C., Horton J.D., Hobbs H.H. Human fatty liver disease: old questions and new insights. Science 2011, 332:1519-1523.
    • (2011) Science , vol.332 , pp. 1519-1523
    • Cohen, J.C.1    Horton, J.D.2    Hobbs, H.H.3
  • 215
    • 80054740637 scopus 로고    scopus 로고
    • The city of "Hepar": rituals, gastronomy, and politics at the origins of the modern names for the liver
    • Riva M.A., Riva E., Spicci M., et al. The city of "Hepar": rituals, gastronomy, and politics at the origins of the modern names for the liver. Journal of Hepatology 2011, 55:1132-1136.
    • (2011) Journal of Hepatology , vol.55 , pp. 1132-1136
    • Riva, M.A.1    Riva, E.2    Spicci, M.3
  • 217
    • 33847404482 scopus 로고    scopus 로고
    • Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in non-alcoholic fatty liver disease
    • Samuel V.T., Liu Z.X., Wang A., et al. Inhibition of protein kinase Cepsilon prevents hepatic insulin resistance in non-alcoholic fatty liver disease. Journal of Clinical Investigation 2007, 117:739-745.
    • (2007) Journal of Clinical Investigation , vol.117 , pp. 739-745
    • Samuel, V.T.1    Liu, Z.X.2    Wang, A.3
  • 219
    • 84901944641 scopus 로고    scopus 로고
    • The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
    • Perry R.J., Samuel V.T., Petersen K.F., et al. The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes. Nature 2014, 510:84-91.
    • (2014) Nature , vol.510 , pp. 84-91
    • Perry, R.J.1    Samuel, V.T.2    Petersen, K.F.3
  • 220
    • 84875164496 scopus 로고    scopus 로고
    • Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia
    • Zammit V.A. Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia. Biochemical Journal 2013, 451:1-12.
    • (2013) Biochemical Journal , vol.451 , pp. 1-12
    • Zammit, V.A.1
  • 222
    • 18144401968 scopus 로고    scopus 로고
    • Associations between liver histology and severity of the metabolic syndrome in subjects with non-alcoholic fatty liver disease
    • Ryan M.C., Wilson A.M., Slavin J., et al. Associations between liver histology and severity of the metabolic syndrome in subjects with non-alcoholic fatty liver disease. Diabetes Care 2005, 28:1222-1224.
    • (2005) Diabetes Care , vol.28 , pp. 1222-1224
    • Ryan, M.C.1    Wilson, A.M.2    Slavin, J.3
  • 223
    • 77649340353 scopus 로고    scopus 로고
    • Practice guidelines for the diagnosis and management of non-alcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee
    • Loria P., Adinolfi L.E., Bellentani S., et al. Practice guidelines for the diagnosis and management of non-alcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Digestive and Liver Disease 2010, 42:272-282.
    • (2010) Digestive and Liver Disease , vol.42 , pp. 272-282
    • Loria, P.1    Adinolfi, L.E.2    Bellentani, S.3
  • 225
    • 46249097997 scopus 로고    scopus 로고
    • Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis
    • Straub B.K., Stoeffel P., Heid H., et al. Differential pattern of lipid droplet-associated proteins and de novo perilipin expression in hepatocyte steatogenesis. Hepatology 2008, 47:1936-1946.
    • (2008) Hepatology , vol.47 , pp. 1936-1946
    • Straub, B.K.1    Stoeffel, P.2    Heid, H.3
  • 226
    • 1942423097 scopus 로고    scopus 로고
    • The pathogenesis of non-alcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis
    • Wanless I.R., Shiota K. The pathogenesis of non-alcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Seminars in Liver Disease 2004, 24:99-106.
    • (2004) Seminars in Liver Disease , vol.24 , pp. 99-106
    • Wanless, I.R.1    Shiota, K.2
  • 228
    • 28844446679 scopus 로고    scopus 로고
    • Hepatic steatosis and insulin resistance: does etiology make a difference?
    • Lonardo A., Lombardini S., Scaglioni F., et al. Hepatic steatosis and insulin resistance: does etiology make a difference?. Journal of Hepatology 2006, 44:190-196.
    • (2006) Journal of Hepatology , vol.44 , pp. 190-196
    • Lonardo, A.1    Lombardini, S.2    Scaglioni, F.3
  • 229
    • 77953893410 scopus 로고    scopus 로고
    • Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia
    • Amaro A., Fabbrini E., Kars M., et al. Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia. Gastroenterology 2010, 139:149-153.
    • (2010) Gastroenterology , vol.139 , pp. 149-153
    • Amaro, A.1    Fabbrini, E.2    Kars, M.3
  • 230
    • 59449105143 scopus 로고    scopus 로고
    • Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?
    • Ballestri S., Lonardo A., Losi L., et al. Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia?. Internal and Emergency Medicine 2009, 4:71-73.
    • (2009) Internal and Emergency Medicine , vol.4 , pp. 71-73
    • Ballestri, S.1    Lonardo, A.2    Losi, L.3
  • 231
    • 65549151428 scopus 로고    scopus 로고
    • The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans
    • Kantartzis K., Machicao F., Machann J., et al. The DGAT2 gene is a candidate for the dissociation between fatty liver and insulin resistance in humans. Clinical Science (London) 2009, 116:531-537.
    • (2009) Clinical Science (London) , vol.116 , pp. 531-537
    • Kantartzis, K.1    Machicao, F.2    Machann, J.3
  • 232
    • 70350550096 scopus 로고    scopus 로고
    • Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene
    • Kantartzis K., Peter A., Machicao F., et al. Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 2009, 58:2616-2623.
    • (2009) Diabetes , vol.58 , pp. 2616-2623
    • Kantartzis, K.1    Peter, A.2    Machicao, F.3
  • 233
    • 84893760888 scopus 로고    scopus 로고
    • PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome
    • Shen J., Wong G.L., Chan H.L., et al. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome. Alimentary Pharmacology and Therapeutics 2014, 39:532-539.
    • (2014) Alimentary Pharmacology and Therapeutics , vol.39 , pp. 532-539
    • Shen, J.1    Wong, G.L.2    Chan, H.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.